BioSpace News Archive

Business

Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024

Azenta, Inc. reported financial results for the second quarter ended March 31, 2024.

May 8, 2024
·
31 min read
Business

Personalis Reports First Quarter 2024 Financial Results

Personalis, Inc., a leader in advanced genomics for precision oncology, reported financial results for the first quarter of 2024 ended March 31, 2024, and provided recent business highlights.

May 8, 2024
·
10 min read
Business

Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the first quarter ended March 31, 2024.

May 8, 2024
·
11 min read
Business

QuidelOrtho Reports First Quarter 2024 Financial Results

QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs, and transfusion medicine, today announced financial results for the first quarter ended March 31, 2024.

May 8, 2024
·
15 min read
Business

Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update

Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX) today reported financial results for the first quarter of 2024 and provided a business update.

May 8, 2024
·
12 min read
Business

MannKind Corporation Reports 2024 First Quarter Financial Results: Provides Clinical Development UpdateConference Call to Begin Today at 5:00 p.m. (ET)

MannKind Corporation reported financial results for the quarter ended March 31, 2024.

May 8, 2024
·
14 min read
Business

Catalent, Inc. Reports Third Quarter Fiscal 2024 Results

Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, announced financial results for the third quarter of fiscal 2024, which ended March 31, 2024.

May 8, 2024
·
32 min read
Biotech Beach

Travere Therapeutics to Present at Upcoming Investor Conferences - May 08, 2024

Travere Therapeutics, Inc. announced that company management will participate in the following upcoming investor conferences.

May 8, 2024
·
1 min read
Biotech Bay

Tivic Health Announces Successful Completion of Non-Invasive Vagus Nerve Stimulation Study (VNS); Demonstrates Clinically Effective Biological Changes in the Autonomic, Cardiac, and Central Nervous Systems

Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today the final results of their pilot research study with The Feinstein Institutes for Medical Research at Northwell Health.

May 8, 2024
·
6 min read
Drug Development

CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer

CEL-SCI Corporation (NYSE American: CVM) today announced a significantly positive outcome from its recent meeting with the U.S. Food and Drug Administration (FDA) regarding the path to approval for its first-line investigational cancer immunotherapy Multikine* (Leukocyte Interleukin, Injection).

May 8, 2024
·
7 min read